AU2003286245A1 - Silicon compounds to be used as ligands for retinoid receptors - Google Patents

Silicon compounds to be used as ligands for retinoid receptors

Info

Publication number: AU2003286245A1
Authority: AU; Australia
Prior art keywords: ligands; silicon compounds; retinoid receptors; retinoid; receptors
Prior art date: 2002-11-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003286245A

Inventor

John Gary Montana

Graham Andrew Showell

Reinhold Tacke

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Paradigm Therapeutics Ltd

Original Assignee

Amedis Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-25

Filing date

2003-11-19

Publication date

2004-06-18

2002-11-25 Priority claimed from GB0227448A external-priority patent/GB0227448D0/en

2003-07-09 Priority claimed from GB0316113A external-priority patent/GB0316113D0/en

2003-11-19 Application filed by Amedis Pharmaceuticals Ltd filed Critical Amedis Pharmaceuticals Ltd

2004-06-18 Publication of AU2003286245A1 publication Critical patent/AU2003286245A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2003286245A 2002-11-25 2003-11-19 Silicon compounds to be used as ligands for retinoid receptors Abandoned AU2003286245A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0227448.8		2002-11-25
GB0227448A GB0227448D0 (en)	2002-11-25	2002-11-25	Compounds and their use
GB0316113A GB0316113D0 (en)	2003-07-09	2003-07-09	Compounds and their use
GB0316113.0		2003-07-09
PCT/GB2003/005026 WO2004048391A1 (en)	2002-11-25	2003-11-19	Silicon compounds to be used as ligands for retinoid receptors

Publications (1)

Publication Number	Publication Date
AU2003286245A1 true AU2003286245A1 (en)	2004-06-18

Family

ID=32395881

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003286245A Abandoned AU2003286245A1 (en)	2002-11-25	2003-11-19	Silicon compounds to be used as ligands for retinoid receptors

Country Status (2)

Country	Link
AU (1)	AU2003286245A1 (en)
WO (1)	WO2004048391A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8765719B2 (en)	2008-09-22	2014-07-01	Kagoshima University	Therapeutic drug for adult T-cell leukemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5648514A (en) *	1994-12-29	1997-07-15	Allergan	Substituted acetylenes having retinoid-like biological activity
US5675024A (en) *	1995-11-22	1997-10-07	Allergan	Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5741896A (en) *	1996-06-21	1998-04-21	Allergan	O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
AU774538B2 (en) *	1999-06-11	2004-07-01	Allergan, Inc.	Organosilyl compounds having nuclear hormone receptor modulating activity
US6479670B1 (en) *	1999-08-25	2002-11-12	Hoffmann-La Roche Inc.	Selective retinoid acid receptor agonists
US6613917B1 (en) *	2000-03-23	2003-09-02	Allergan, Inc.	Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
KR100608405B1 (en) *	2000-05-02	2006-08-02	에프. 호프만-라 로슈 아게	New gamma selective retinoids

2003
- 2003-11-19 WO PCT/GB2003/005026 patent/WO2004048391A1/en not_active Ceased
- 2003-11-19 AU AU2003286245A patent/AU2003286245A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004048391A1 (en)	2004-06-10

Similar Documents

Publication	Publication Date	Title
AU2003227909A1 (en)	2003-11-17	Imidazo-triazine derivatives as ligands for gaba receptors
IS050094A (en)	2014-10-28	Process to make glucocorticoid compounds
AU2002329877A1 (en)	2003-12-02	Cross reference to related art
AU2003286263A1 (en)	2004-06-23	Complexes of receptors
GB0420044D0 (en)	2004-10-13	Antibodies to m-csf
AU2003290734A1 (en)	2004-06-23	Novel compounds as pharmaceutical agents
AU2003902860A0 (en)	2003-06-26	Benzimidazole compounds
AU2002215100A1 (en)	2002-05-21	Imidazo-pyrimidine derivatives as ligands for gaba receptors
AU2003234706A1 (en)	2003-11-03	Antibodies that specifically bind to tl5
AU2003252971A1 (en)	2004-02-25	Pyridazine derivatives as ligands for gaba receptors
AU2001270822A1 (en)	2002-01-30	Imidazolophthalazine derivatives as ligands for gabaa receptors
AU2003215635A1 (en)	2003-10-13	Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003282510A1 (en)	2004-05-04	Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
AU2003225956A1 (en)	2003-10-13	Apparatus for automatic application of compositions to the skin
AU2003286245A1 (en)	2004-06-18	Silicon compounds to be used as ligands for retinoid receptors
AU2003297597A1 (en)	2004-06-18	Benzimidazoles and analogs thereof as antibacterials
AU2003229884A1 (en)	2003-10-27	Imidazo-pyridine derivatives as ligands for gaba receptors
AU2003219312A1 (en)	2003-10-27	Imidazo-pyridine derivatives as ligands for gaba receptors
AU2003217065A1 (en)	2003-10-27	Improvements relating to cameras
AU2002235543A1 (en)	2002-03-04	Imidazolophthalazine derivatives as ligands for gabaa receptors
AU2003260509A1 (en)	2004-04-08	Acetylene compounds
AU2002344864A1 (en)	2003-10-27	Apparatus for determining positioning relative to utility lines
AU2003232510A1 (en)	2003-11-17	Alkyne compounds
AU2003226150A1 (en)	2003-10-20	Grignard preparation of unsaturated organic compounds
AU2003228162A1 (en)	2003-11-17	Improvements relating to heatsinks

Legal Events

Date	Code	Title	Description
2005-08-11	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase